A broad coalition of healthcare organizations urged Congress to advance the H.R. 2213, the Medical Supply Chain Resiliency Act, bipartisan legislation to strengthen and diversify the U.S. medical supply chain by promoting domestic manufacturing and partnerships with trusted global allies. The bill would help prevent shortages, improve access to critical medical products, and support high-quality, affordable patient care.
To Congress
Group letter to House W&M Committee urging passage of H.R. 2213, the Medical Supply Chain Resiliency Act
- Topics: Innovation, Patient Safety and Quality, Workforce Shortage
Related Letters & Comments
HLC drives policy change through strategic letters, comments, and reports that promote private-sector innovation. Focused on priorities like Medicare reform, telehealth, and health equity, HLC engages with lawmakers and agencies to shape a smarter, more responsive healthcare system.
To Congress
Group letter to House W&M Committee urging passage of H.R. 2213, the Medical Supply Chain Resiliency Act
A broad coalition of healthcare organizations urged Congress to advance the H.R. 2213, the Medical Supply Chain Resiliency Act, bipartisan legislation to strengthen and diversify the U.S. medical supply chain by promoting domestic manufacturing and…
To The Administration
Group letter to CMS with recommendations on H.R.1 implementation
The letter thanks the agency for incorporating several coalition recommendations into recent guidance implementing the Working Families Tax Cut legislation and offers additional recommendations to help minimize coverage losses among eligible individ…
To Congress
Group letter endorsing the Chronic Care Management Improvement Act
The bill would remove the 20% coinsurance requirement associated with Medicare’s Chronic Care Management (CCM) code, a barrier that has contributed to significant underutilization of care management services. These services have been shown to improv…
